Pallayova Maria, Rayner Hugh, Taheri Shahrad, Dasgupta Indranil
Renal Unit, Heartlands Hospital, Bordesley Green East, Birmingham, UK; Department of Human Physiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Slovak Republic.
Renal Unit, Heartlands Hospital, Bordesley Green East, Birmingham, UK.
J Diabetes Complications. 2015 Aug;29(6):761-5. doi: 10.1016/j.jdiacomp.2015.05.012. Epub 2015 May 29.
We examined potential ethnicity-related differences in progression of chronic kidney disease (CKD) between South Asian and white European diabetic adults with CKD stage 3 over a 5-year period.
We analysed data collected from diabetic adults of white European and South Asian ethnicity who had attended diabetes and diabetes-renal outpatient clinics with baseline estimated glomerular filtration rate (eGFR) values ≥30 and <60 ml/min/1.73 m(2) over 5 years (2005-2010); 891 (76%) were white Europeans, 282 (24%) were South Asians.
Despite similar baseline eGFR (P=0.103), South Asians were younger [median (interquartile range) 68 (63-73) vs. 70 (64-77) years; P<0.001] and had worse baseline glycated haemoglobin than white Europeans [8.0 (7.0-9.1) vs. 7.6 (6.8-8.7)%; P=0.004]. The 5-year follow-up eGFR and the decline in eGFR did not differ between the two groups. Thirty-five (12.4%) South Asians and 82 (9.2%) white Europeans progressed to stages 4-5 CKD (P=0.112). There was a trend towards higher follow-up glycated haemoglobin levels in South Asians (P=0.064).
Despite worse glycaemic control, South Asian diabetic adults with CKD stage 3 did not show any difference in 5-year decline in eGFR compared with white Europeans. These data do not support ethnic differences in progression of CKD between the South Asian and white European patient populations.
我们研究了南亚裔和欧洲裔白人糖尿病成年慢性肾脏病(CKD)3期患者在5年期间CKD进展方面潜在的种族差异。
我们分析了从欧洲裔白人和南亚裔糖尿病成年患者收集的数据,这些患者在5年期间(2005 - 2010年)因糖尿病和糖尿病肾病就诊于门诊,基线估计肾小球滤过率(eGFR)值≥30且<60 ml/min/1.73 m²;891例(76%)为欧洲裔白人,282例(24%)为南亚裔。
尽管基线eGFR相似(P = 0.103),但南亚裔患者更年轻[中位数(四分位间距)68(63 - 73)岁对70(64 - 77)岁;P < 0.001],且基线糖化血红蛋白水平比欧洲裔白人更差[8.0(7.0 - 9.1)%对7.6(6.8 - 8.7)%;P = 0.004]。两组间5年随访eGFR及eGFR下降情况无差异。35例(12.4%)南亚裔和82例(9.2%)欧洲裔白人进展至CKD 4 - 5期(P = 0.112)。南亚裔患者随访糖化血红蛋白水平有升高趋势(P = 0.064)。
尽管血糖控制较差,但CKD 3期的南亚裔糖尿病成年患者与欧洲裔白人相比,5年eGFR下降无差异。这些数据不支持南亚裔和欧洲裔白人患者群体在CKD进展方面存在种族差异。